Jessica Marie Sotelo

Recommended Articles

• Letting Go: How to Live with Fibromyalgia

  Fibromyalgia is a great example of a condition that can seriously impact the way all activities are carried out on a daily basis. However, with the correct mindset, people can easily overcome a situation, no matter how difficult may seem.In many cases, people do not have a positive attitude with...

• How Is Shingles Treated?

  Shingles, or herpes zoster, refers to the painful skin rashes caused by the varicella zoster virus. In this condition, a band of rashes usually appears in a small area on the face or body. This infection is very common in people who have a weak immune system due to various reasons. Older adults are...

• Is Legionnaires' Disease a Serious Medical Condition?

  Legionella bacteriaLegionnaires' disease is a type of pneumonia that is in its most severe form. The disease occurs due to a bacterial infection caused by a bacteria called legionella and mainly results in the inflammation of the lungs. The bacteria are known to thrive commonly in areas such as...

• The Potential For Early Multiple Sclerosis Diagnosis with MRI Brain Scans

  Multiple sclerosis can be difficult to diagnose, as many of the symptoms do not even appear until later in one's life. However, a recent study has shown that the risk level in children is able to be diagnosed early with MRI brain scans.DiagnosisSometimes MRI brain scans can show MS before any...

• Diagnosing Epilepsy: What You Need to Know

  Sometimes, it can be difficult to know if an individual is having a bout of seizure. It is also not easy for physicians to make a diagnosis on what type of epilepsy or seizure a person has since there are various disorders that can be confused with epilepsy.The very first step, and probably the most...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...